Variability in Golimumab Exposure: A 'Real-Life' Observational Study in Active Ulcerative Colitis.
about
Incidence, Prevention and Management of Anti-Drug Antibodies Against Therapeutic Antibodies in Inflammatory Bowel Disease: A Practical Overview.Golimumab for the treatment of ulcerative colitis.Short-term effectiveness of golimumab for ulcerative colitis: Observational multicenter study.Pharmacokinetics and Exposure-response Relationship of Golimumab in Patients with Moderately-to-Severely Active Ulcerative Colitis: Results from Phase 2/3 PURSUIT Induction and Maintenance Studies.Golimumab pharmacokinetics in ulcerative colitis: a literature reviewTherapeutic Drug Monitoring During Induction of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease: Defining a Therapeutic Drug Window.Therapeutic Drug Monitoring of Golimumab in the Treatment of Ulcerative Colitis.Can We Predict the Efficacy of Anti-TNF-α Agents?Practical recommendations for the use of therapeutic drug monitoring of biopharmaceuticals in inflammatory diseases.Golimumab for moderate to severe ulcerative colitis.Pharmacokinetics and Exposure-response Relationship of Golimumab in Patients with Moderately-to-severely Active Ulcerative Colitis: Results from Phase 2/3 PURSUIT Induction and Maintenance Studies.
P2860
Q30235581-BD1AC20E-530B-42C3-8251-B56FDE35D93EQ33852257-F4584A2B-527D-4048-820F-6247931A8FC6Q37522688-0E7B1B06-3745-40A5-B8B4-B0E0512B38C6Q37523503-BE4FBDB7-E12C-4589-9BE5-27776D647465Q37671983-50D1EE0F-EBC3-49E4-B283-E81DB60C851FQ38620415-22187DEA-6A0B-40B3-B2EF-7D9ECCC0E891Q38856947-147CAAB6-5492-482F-8AAB-25A7D7B21E8AQ41660559-91DCD38A-60B2-4935-88BB-0826964D8FD7Q42373188-DA11715E-1D28-40A4-B633-641F360275AAQ50853856-08269394-01DA-4FB7-A6E0-A644A8EEC8C9Q51600613-61F3A807-C305-4178-BA7A-EC66D12CAFFF
P2860
Variability in Golimumab Exposure: A 'Real-Life' Observational Study in Active Ulcerative Colitis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Variability in Golimumab Expos ...... in Active Ulcerative Colitis.
@en
Variability in Golimumab Expos ...... in Active Ulcerative Colitis.
@nl
type
label
Variability in Golimumab Expos ...... in Active Ulcerative Colitis.
@en
Variability in Golimumab Expos ...... in Active Ulcerative Colitis.
@nl
prefLabel
Variability in Golimumab Expos ...... in Active Ulcerative Colitis.
@en
Variability in Golimumab Expos ...... in Active Ulcerative Colitis.
@nl
P2093
P2860
P356
P1476
Variability in Golimumab Expos ...... in Active Ulcerative Colitis.
@en
P2093
Annick de Vries
Els Brouwers
Gert Van Assche
Iris Detrez
Marc Ferrante
Thomas Van Stappen
P2860
P304
P356
10.1093/ECCO-JCC/JJV241
P577
2016-01-06T00:00:00Z